New wart treatment seeks final approval in major trial
Disease control
Recruiting now
This study is testing a topical liquid called YCANTH to see if it can safely and effectively clear common warts. About 300 people aged 2 and up with common warts will have the treatment or a placebo applied to their warts every few weeks. The main goal is to see how many people h…
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC